Goldman Sachs’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $916K | Sell |
460,505
-195,206
| -30% | -$388K | ﹤0.01% | 3900 |
|
2025
Q1 | $951K | Sell |
655,711
-43,638
| -6% | -$63.3K | ﹤0.01% | 3834 |
|
2024
Q4 | $1.45M | Buy |
699,349
+453,018
| +184% | +$938K | ﹤0.01% | 3695 |
|
2024
Q3 | $434K | Buy |
246,331
+204,717
| +492% | +$360K | ﹤0.01% | 4179 |
|
2024
Q2 | $602K | Buy |
+41,614
| New | +$602K | ﹤0.01% | 3860 |
|
2024
Q1 | – | Sell |
-20,314
| Closed | -$326K | – | 4828 |
|
2023
Q4 | $326K | Buy |
20,314
+2,952
| +17% | +$47.4K | ﹤0.01% | 4132 |
|
2023
Q3 | $234K | Sell |
17,362
-13,456
| -44% | -$181K | ﹤0.01% | 4198 |
|
2023
Q2 | $530K | Buy |
30,818
+15,853
| +106% | +$273K | ﹤0.01% | 3954 |
|
2023
Q1 | $247K | Sell |
14,965
-416
| -3% | -$6.88K | ﹤0.01% | 4432 |
|
2022
Q4 | $257K | Buy |
+15,381
| New | +$257K | ﹤0.01% | 4412 |
|